MCID: PLM035
MIFTS: 48

Pulmonary Eosinophilia malady

Categories: Respiratory diseases, Blood diseases

Aliases & Classifications for Pulmonary Eosinophilia

About this section

Aliases & Descriptions for Pulmonary Eosinophilia:

Name: Pulmonary Eosinophilia 10 47 12 65
 
Asthmatic Pulmonary Eosinophilia 65

Classifications:



External Ids:

Disease Ontology10 DOID:9498
ICD9CM29 518.3
MeSH36 D011657
ICD1027 J82
UMLS65 C0034068, C0340076

Summaries for Pulmonary Eosinophilia

About this section
MalaCards based summary: Pulmonary Eosinophilia, also known as asthmatic pulmonary eosinophilia, is related to loeffler syndrome and chronic eosinophilic pneumonia, and has symptoms including hemoptysis An important gene associated with Pulmonary Eosinophilia is IL5 (Interleukin 5), and among its related pathways are CXCR3-mediated signaling events and Inflammatory Response Pathway. Affiliated tissues include lung, breast and t cells, and related mouse phenotypes are respiratory system and hematopoietic system.

Related Diseases for Pulmonary Eosinophilia

About this section

Diseases related to Pulmonary Eosinophilia via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 119)
idRelated DiseaseScoreTop Affiliating Genes
1loeffler syndrome32.3CCL11, CSF2, IL5, RNASE3
2chronic eosinophilic pneumonia29.5CCL11, CSF2, EPX, IL13, IL4, IL5
3asthma26.7CCL11, CCR3, CSF2, CYSLTR1, EPX, IL13
4eosinophilic pneumonia11.6
5carrington syndrome11.5
6eosinophilia10.8
7trabecular follicular adenocarcinoma10.6IL5, RNASE3
8blepharophimosis10.5CCL11, IL5
9cholesteatoma of attic10.5CCL11, IL5
10lattice corneal dystrophy10.5CSF2, IL5
11pars planitis10.5IL13, IL5
12keratoconjunctivitis10.5IL5, RNASE3
13non specific chronic endometritis10.4IL5, RNASE3
14egg allergy10.4IL4, RNASE3
15papillary conjunctivitis10.3CCL11, IL5, RNASE3
16bacterial gastritis10.3CCL11, IL5, RNASE3
17limbic encephalitis with ncmags antibodies10.3IL4, IL5
18gonococcal bursitis10.3IL4, IL5
19giant papillary conjunctivitis10.3CCL11, IL4
20idiopathic interstitial pneumonia10.3IL4, IL5
21winchester syndrome10.3EPX, RNASE3
22balkan nephropathy10.3CCL11, IL5, RNASE3
23antley-bixler syndrome with genital anomalies and disordered steroidogenesis10.3CCL11, IL13, IL5
24juvenile dermatitis herpetiformis10.3CCL11, IL5, RNASE3
25mixed extragonadal germ cell cancer10.3EPX, RNASE3
26verrucous nevus acanthokeratolytic10.2CCL11, IL13, RNASE3
27penicillin allergy10.2IL13, IL4
28central nervous system childhood germ cell tumor10.2CCL11, IL13, IL5
29postmenopausal atrophic vaginitis10.2CCL11, IL13, IL5
30mobitz type ii atrioventricular block10.2IL4, IL5
31steatorrhea10.2CSF2, IL13, IL5
32skin conditions10.2CYSLTR1, IL5, RNASE3
33extrapulmonary tuberculosis10.2IL13, IL4
34kyphoscoliotic heart disease10.2IL4, IL5, RNASE3
35status asthmaticus10.2IL4, IL5, RNASE3
36granulomatous amebic encephalitis10.1IL4, IL5
37hypertensive encephalopathy10.1CCL11, IL4
38idiopathic acute eosinophilic pneumonia10.1
39anterior dislocation of lens10.1CCL11, IL4, RNASE3
40hepatitis e10.1CCL11, IL4, IL5
41baylisascariasis10.1IL13, IL4, IL5
42epididymis cancer10.1IL13, IL4, IL5
43acantholytic variant squamous cell breast carcinoma10.1IL13, IL4, IL5
44spleen angiosarcoma10.0IL4, IL5
45cow milk allergy10.0IL13, IL4
46hypergonadotropic ovarian failure, familial or sporadic10.0EPX, IL5, RNASE3
47filariasis10.0
48spinal canal intradural extramedullary neoplasm10.0CCL11, IL13, IL4
49goat milk allergy9.9IL4, RNASE3
50pneumonia9.9

Comorbidity relations with Pulmonary Eosinophilia via Phenotypic Disease Network (PDN):


BronchitisCoronary Artery Disease
Deficiency AnemiaFamilial Atrial Fibrillation
Heart DiseaseIron Deficiency Anemia
Ischemic Heart DiseasePostinflammatory Pulmonary Fibrosis
Protein-Energy MalnutritionActive Peptic Ulcer Disease
Acute CystitisChronic Kidney Failure
Decubitus UlcerEsophagitis
Respiratory FailureSchizophreniform Disorder

Graphical network of the top 20 diseases related to Pulmonary Eosinophilia:



Diseases related to pulmonary eosinophilia

Symptoms for Pulmonary Eosinophilia

About this section

UMLS symptoms related to Pulmonary Eosinophilia:


hemoptysis

Drugs & Therapeutics for Pulmonary Eosinophilia

About this section

Drugs for Pulmonary Eosinophilia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 97)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Nitric OxideapprovedPhase 4, Phase 256410102-43-9145068
Synonyms:
(.)NO
(NO)(.)
10102-43-9
14332-28-6
295566_ALDRICH
51005-20-0
51005-21-1
53851-19-7
90452-29-2
AC1L1ADQ
AC1L3QHF
AC1Q6QZ0
AR-1K7463
Bioxyde d'azote
Bioxyde d'azote [French]
C00533
CCRIS 4319
CHEMBL1200689
CHEMBL1234765
CID145068
CID945
D00074
D009569
DB00435
EDRF
EINECS 233-271-0
Endogenous Nitrate Vasodilator
Endothelium-Derived Nitric Oxide
HNO
HSDB 1246
INOmax
INOmax (TN)
Inomax
LS-192158
LS-7547
MolPort-003-929-452
Mononitrogen monoxide
Monoxide, Mononitrogen
Monoxide, Nitrogen
Monoxido de nitrogeno
Monoxyde d'azote
NITRIC-OXIDE
NO
NO(.)
Nitrate Vasodilator, Endogenous
Nitric Oxide, Endothelium Derived
 
Nitric Oxide, Endothelium-Derived
Nitric oxide
Nitric oxide (JAN)
Nitric oxide 10% by volume or more
Nitric oxide trimer
Nitric oxide, compressed [UN1660] [Poison gas]
Nitric oxide, compressed [UN1660] [Poison gas]
Nitrogen monoxide
Nitrogen oxide
Nitrogen oxide (NO)
Nitrogen protoxide
Nitrosyl
Nitrosyl hydride
Nitrosyl hydride ((NO)H)
Nitrosyl radical
Nitroxide radical
Nitroxyl
OHM 11771
Oxide, Nitric
Oxido de nitrogeno(ii)
Oxido nitrico
Oxyde azotique
Oxyde nitrique
Oxyde nitrique [French]
RCRA waste no. P076
Stickmonoxyd
Stickmonoxyd [German]
Stickstoff(II)-oxid
Stickstoff(ii)-oxid
Stickstoffmonoxid
UN 1660
UN1660
UNII-31C4KY9ESH
Vasodilator, Endogenous Nitrate
[NO]
endothelium-derived relaxing factor
monoxido de nitrogeno
monoxyde d'azote
nitric oxide
nitrogen monooxide
nitrogen monoxide
nitrosyl
oxido de nitrogeno(II)
oxido nitrico
oxidonitrogen(.)
oxoazanyl
oxyde azotique
2
PrednisoloneapprovedPhase 4108250-24-85755
Synonyms:
(11beta)-11,17,21-Trihydroxypregna-1,4-diene-3,20-dione
.DELTA.1-Cortisol
.DELTA.1-Dehydrocortisol
.DELTA.1-Dehydrohydrocortisone
.DELTA.1-Hydrocortisone
.delta.-Cortef
.delta.-Stab
1,2-Dehydrohydrocortisone
1,4-Pregnadiene-11beta,17alpha,21-triol-3,20-dione
1,4-Pregnadiene-3,20-dione-11beta,17alpha,21-triol
1-Dehydrocortisol
1-Dehydrohydrocortisone
3,20-dioxo-11beta,17alpha,21-Trihydroxy-1,4-pregnadiene
46656_FLUKA
46656_RIEDEL
50-24-8
58201-11-9
8056-11-9
AC-1773
AC1L1L2E
Ak-Pred
Ak-Tate
Alphadrol
Articulose-50
BPBio1_000164
BRD-K98039984-001-03-0
BRN 1354103
BSPBio_000148
Bio-0666
Bubbli-Pred
C07369
CCRIS 980
CHEBI:8378
CHEMBL131
CID5755
CO-Hydeltra
CPD000718761
Co-Hydeltra
Codelcortone
Cordrol
Cortalone
Cotogesic
Cotolone
D00472
D011239
DB00860
Decaprednil
Decortin H
Delcortol
Delta F
Delta(1)-dehydrohydrocortisone
Delta-Cortef
Delta-Cortef (TN)
Delta-Ef-Cortelan
Delta-Stab
Delta-stab
Deltacortenol
Deltacortril
Deltacortril Enteric
Deltahydrocortisone
Deltasolone
Deltisilone
Depo-Medrol
Derpo PD
Derpo Pd
Dexa-Cortidelt Hostacortin H
Dexa-Cortidelt hostacortin H
Di Adreson F
Di-Adreson F
Di-Adreson-F
Di-adreson F
DiAdresonF
Dicortol
Donisolone
Dydeltrone
EINECS 200-021-7
Eazolin D
Econopred
Econopred Plus
Erbacort
Erbasona
Estilsona
Fernisolone
Fernisolone P
Fernisolone-P
Flamasone
Flo-pred
HMS1568H10
HMS2090J05
HSDB 3385
Hostacortin H
Hydeltra
Hydeltra-Tba
Hydeltrasol
Hydeltrone
Hydrodeltalone
Hydrodeltisone
Hydroretrocortin
Hydroretrocortine
I-Pred
Inflamase Forte
Inflamase Mild
K 1557
Key-Pred
Klismacort
LMST02030179
LS-7669
Lentosone
Lite Pred
M-Predrol
MLS001304083
 
MLS002154250
MLS002207037
Medrol
Medrol Acetate
Metacortandralone
Methylprednisolone Acetate
Meti-Derm
Meticortelone
Metreton
Millipred
MolPort-002-507-147
NCGC00179649-01
NSC 9120
NSC9120
NSC9900
Neo-Delta-Cortef
Nisolone
Nor-Pred T.B.A.
Ocu-Pred
Ocu-Pred Forte
Omnipred
Ophtho-Tate
Orapred
P0152_SIGMA
P0637
P6004_SIGMA
PRDL
PRED-G
Panafcortelone
Paracortol
Paracotol
Pediapred
Poly-Pred
Precortalon
Precortancyl
Precortilon
Precortisyl
Pred Forte
Pred Mild
Predair
Predair A
Predair Forte
Predalone 50
Predalone T.B.A.
Predate
Predate Tba
Predate-50
Predcor-25
Predcor-50
Predcor-Tba
Predisolone Sodium Phosphate
Predne-Dome
Prednelan
Predni-Dome
Prednicen
Predniliderm
Predniretard
Prednis
Prednisolona
Prednisolona [INN-Spanish]
Prednisolone
Prednisolone (JP15/USP/INN)
Prednisolone (anhydrous)
Prednisolone Acetate
Prednisolone Sodium Phosphate
Prednisolone Tebutate
Prednisolone [INN:BAN:JAN]
Prednisolonum
Prednisolonum [INN-Latin]
Predonin
Predonine
Prelone
Prenolone
Prestwick0_000274
Prestwick1_000274
Prestwick2_000274
Prestwick3_000274
Prestwick_404
Rolisone
S1737_Selleck
SAM002264639
SMR000718761
SPBio_002367
Scherisolon
Solone
Steran
Sterane
Sterolone
Supercortisol
UNII-9PHQ9Y1OLM
Ulacort
Ultra Pred
Ultracorten H
Ultracortene H
Ultracortene-H
Ultracortene-Hydrogen
Ultracortene-hydrogen
ZINC03833821
component of Ataraxoid
component of K-Predne-Dome
delta(1)-Cortisol
delta(1)-Dehydrocortisol
delta(1)-Dehydrohydrocortisone
delta(1)-Hydrocortisone
delta(sup 1)-Cortisol
delta(sup 1)-Dehydrocortisol
delta(sup 1)-Dehydrohydrocortisone
delta(sup 1)-Hydrocortisone
delta-dehydrocortisol
delta-dehydrohydrocortisone
delta-hydrocortisone
prednisolone
3
MethylprednisoloneapprovedPhase 4108283-43-26741
Synonyms:
(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
(6a,11b)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6alpha,11beta)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6α,11β)-11,17,21-trihydroxy-6-methylpregna-1,4-diene-3,20-dione
.DELTA.1-6.alpha.-Methylhydrocortisone
1-Dehydro-6alpha-methylhydrocortisone
1-dehydro-6alpha-Methylhydrocortisone
1-dehydro-6α-methylhydrocortisone
11-beta,17,21-Trihydroxy-6-alpha-methylpregna-1,4-diene-3,20-dione
11beta,17,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
11beta,17alpha,21-Trihydroxy-6alpha-methyl-1,4-pregnadiene-3,20-dione
11beta,17alpha,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
121673-01-6
4-08-00-03498 (Beilstein Handbook Reference)
46436_FLUKA
46436_RIEDEL
570-35-4
6 Methylprednisolone
6-Methylprednisolone
6-alpha-Methylprednisolone
6.alpha.-Methylprednisolone
6923-42-8
6alpha-Methyl-11beta,17alpha,21-trihydroxy-1,4-pregnadiene-3,20-dione
6alpha-Methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione
6alpha-Methylprednisolone
6alpha-methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione
83-43-2
A-methapred
AC1L1N7A
Artisone-Wyeth
Artisone-wyeth
BPBio1_000174
BRD-K35240538-001-03-1
BRN 2340300
BSPBio_000158
Besonia
Bio-0658
CHEBI:6888
CHEMBL650
CID6741
CPD000058330
D00407
D008775
DB00959
Depo-Medrol (acetate)
Depo-medrol
Dopomedrol
EINECS 201-476-4
Esametone
Firmacort
HMS1568H20
HMS2090B13
HSDB 3127
LMST02030178
LS-118498
Lemod
M0639_SIGMA
M1665
MEPRDL
MLS000028541
MLS001148159
MLS002207191
Medesone
Medixon
Medlone 21
 
Medrate
Medrol
Medrol (TN)
Medrol Adt Pak
Medrol Dosepak
Medrol adt pak
Medrol dosepak
Medrol, Solu-Medrol, Medrone, Methylprednisolone
Medrone
Mesopren
Metastab
Methyleneprednisolone
Methylprednisolon
Methylprednisolone
Methylprednisolone (JP15/USP/INN)
Methylprednisolone [USAN:INN:BAN:JAN]
Methylprednisolone, 6-alpha
Methylprednisolonum
Methylprednisolonum [INN-Latin]
Metilbetasone
Metilprednisolona
Metilprednisolona [INN-Spanish]
Metilprednisolone
Metilprednisolone [DCIT]
Metilprednisolone [Dcit]
Metipred
Metrisone
Metrocort
Metysolon
Moderin
MolPort-002-528-554
NCGC00022735-03
NCI60_001657
NSC-19987
NSC19987
Nirypan
Noretona
Predni N Tablinen
Prednol- L
Pregna-1,4-diene-3,20-dione, 11beta,17,21-trihydroxy-6alpha-methyl- (8CI)
Prestwick0_000279
Prestwick1_000279
Prestwick2_000279
Prestwick3_000279
Prestwick_622
Promacortine
Reactenol
S1733_Selleck
SAM002589984
SMR000058330
SPBio_002377
Sieropresol
Solomet
Solu-medrol
Summicort
Suprametil
U 7532
UNII-X4W7ZR7023
Urbason
Urbasone
Wyacort
ZINC03875560
delta(1)-6alpha-Methylhydrocortisone
delta(sup 1)-6-alpha-Methylhydrocortisone
methylprednisolone
methylprenisolone
4
Omalizumabapproved, investigationalPhase 4137242138-07-4
Synonyms:
242138-07-4
D05251
Ig gamma-1 chain C region
Omalizumab
 
Omalizumab (USAN/INN)
Omalizumab (genetical recombination)
Omalizumab (genetical recombination) (JAN)
Xolair
Xolair (TN)
5
Ciclesonideapproved, investigationalPhase 474141845-82-1444033
Synonyms:
(R)-11beta,16alpha,17,21-Tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with cyclohexanecarboxaldehyde, 21-isobutyrate
126544-47-6
141845-82-1
AC-1330
Alvesco
Alvesco (TN)
Alvesco HFA
B-9207-015
BTR-15
BTR-15K
BY-9010
BYK-20426
CID6918155
Ciclesonide
 
Ciclesonide (JAN/USAN/INN)
Ciclesonide [INN]
D01703
KS-1165
LS-186047
MolPort-005-940-705
NCGC00167972-01
Omnair
Omnaris
Omnaris HFA
Osonase
Osonide
RPR 251526
TBN-15
UNII-S59502J185
Zetonna
6
BudesonideapprovedPhase 438151333-22-363006, 5281004
Synonyms:
(11-beta,16-alpha)-16,17-(Butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dione
(11beta,16alpha)-16,17-(Butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dione
(4aR,4bS,5S,6aS,6bS,8R,9aR,10aS,10bS)-5-hydroxy-6b-(hydroxyacetyl)-4a,6a-dimethyl-8-propyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one
(4aR,4bS,5S,6aS,6bS,9aR,10aS,10bS)-5-hydroxy-6b-(hydroxyacetyl)-4a,6a-dimethyl-8-propyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one
(R,S)-11b,16a,17,21,tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with buty raldehyde
(RS)-(11beta,16alpha)-16,17-[Butylidenebis(oxy)]-11,21-dihydroxypregna-1,4-diene-3,20-dione
(RS)-11beta,16alpha,17,21-Tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with butyraldehyde
(S)-16alpha,17-(Butylidenedioxy)-11beta,21-dihydroxypregna-1,4-diene-3,20-dione
11beta,21-dihydroxy-16alpha,17alpha-(butane-1,1-diyldioxy)pregna-1,4-diene-3,20-dione
16,17-Butylidenebis(oxy)-11,21-dihydroxypregna-1,4-diene-3,20-dione
16,17-Butylidenebis(oxy)-11-,21-dihydroxypregna-1,4-diene-3,20-dione
16-alpha,17-alpha-Butylidenedioxy-11-beta,21-dihydroxy-1,4-pregnadiene-3,20-dione
16alpha(R),17-(Butylidenebis(oxy))-11beta,21-dihydroxypregna-1,4-diene-3,20-dione
16alpha-,17alpha--butylidenedioxypregna-1,4-diene-11beta-,21-diol-3,20-dione
51333-22-3
AC-4697
AC1L1DQE
AC1L1Y6Y
AC1L22VC
AC1MHWI7
B 7777
B7777_SIGMA
BPBio1_000523
BRD-A34299591-001-03-4
BRD-A82238138-001-01-7
BSPBio_000475
BSPBio_002160
Bidien
Bio-0010
Budecort Inhaler
Budenofalk
Budeson
Budesonide
Budesonide (JAN/USAN/INN)
Budesonide Easyhaler
Budesonide Inhalation
Budesonide MMX
Budesonide Nasal
Budesonide [USAN:INN:BAN:JAN]
Budesonido
Budesonido [INN-Spanish]
Budesonidum
Budesonidum [INN-Latin]
Budiair
Budicort
C25H34O6
CCRIS 5230
CHEBI:3207
CHEBI:656601
CHEMBL1370
CID2462
CID3033890
CID40000
CID5281004
CID63006
CPD000058337
Cortivent
D00246
DB01222
Desowen
Dexbudesonide
Dexbudesonide [INN]
DivK1c_000475
EINECS 257-139-7
EINECS 257-160-1
EINECS 257-161-7
EU-0100174
Entocort
Entocort EC
Entocort EC (TN)
Giona Easyhaler
HMS1569H17
HMS1921I22
HMS2094I13
HMS501H17
 
Horacort
IDI1_000475
Inflammide
KBio1_000475
KBio3_001660
KBioGR_001361
LS-187734
LS-7235
Lopac0_000174
MAP-0010
MLS000028507
MLS001077323
MLS002207112
Micronyl
Miflonide
MolPort-002-529-265
MolPort-003-666-332
MolPort-003-986-909
NCGC00015165-03
NCGC00021318-03
NCGC00021318-06
NCGC00089747-02
NCGC00089747-03
NCGC00089747-04
NCGC00178789-01
NINDS_000475
Noex
Preferid
Pregna-1,4-diene-3,20-dione, 16,17-butylidenebis(oxy)-11,21-dihydroxy-, (11beta,16alpha(R))-, and 16alpha,17-((S)-Butylidenebis(oxy))-11beta,21-dihydroxypregna-1,4-diene-3,20-dione
Prestwick0_000518
Prestwick1_000518
Prestwick2_000518
Prestwick3_000518
Prestwick_840
Pulmaxan
Pulmaxan turbohaler
Pulmicort
Pulmicort (TN)
Pulmicort FLEXHALER
Pulmicort Flexhaler
Pulmicort Nebuamp
Pulmicort Respules
Pulmicort Topinasal
Pulmicort Turbuhaler
Pulmicort turbuhaler
Respules
Rhinocort
Rhinocort Aqua
Rhinocort Turbuhaler
Rhinocort alpha
Rhinocort, Pulmicort , Entocort, Symbicort, Noex. Entocort EC, Budesonide
Rhinosol
S 1320
S-1320
S1286_Selleck
SAM002699898
SMR000058337
SPBio_000586
SPBio_002396
SPECTRUM1500813
ST51039033
Spectrum2_000623
Spectrum3_000620
Spectrum4_000821
Spectrum5_001738
Spirocort
TL8003397
Tridesilon
UDB
UNII-168L5HT37P
UNII-2HI1006KPH
UNII-Q3OKS62Q6X
Uceris
Unit dose budesonide
ZINC03938751
ZINC04097286
budesonide
7
MontelukastapprovedPhase 4264158966-92-85281040
Synonyms:
(R-(E))-1-(((1-(3-(2-(7-Chloro-2-quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)cyclopropaneacetic acid
(R-(e))-1-(((1-(3-(2-(7-Chloro-2-quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)cyclopropaneacetic acid
1-((((1R)-1-(3-((1E)-2-(7-Chloro-2-quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)cyclopropaneacetic acid
1-[[[(1 R)-1-[3-[(1e)-2-(7-chloro-2-Quinolinyl)ethenyl] phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]sulfanyl]methyl]cyclopropaneacetic acid
151767-02-1 (sodium)
158966-92-8
2-[1-[[(1R)-1-[3-[(E)-2-(7-chloroquinolin-2-yl)ethenyl]phenyl]-3-[2-(2-hydroxypropan-2-yl)phenyl]propyl]sulfanylmethyl]cyclopropyl]acetic acid
AC1NQXXW
Apxi toxin
BIDD:GT0394
Brondilat
Brondilat (TN)
C07482
C35H36ClNO3S
CHEBI:50730
CHEMBL787
CID5281040
D08229
 
DB00471
HMS2089D07
HSDB 7582
LS-173539
MK 0476
MK-0476
Montair
Montelukast
Montelukast (INN)
Montelukast Sodium
Montelukast [INN:BAN]
Montelukast sodium
Montelukastum
Montélukast
Singulair
Singular
UNII-MHM278SD3E
montelukast
sodium 1-(((1-(3-(2-(7-chloro-2-quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)cyclopropylacetate
{1-[({(1R)-1-{3-[(E)-2-(7-chloroquinolin-2-yl)ethenyl]phenyl}-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl}sulfanyl)methyl]cyclopropyl}acetic acid
8Adrenergic beta-2 Receptor AgonistsPhase 4, Phase 2741
9Adrenergic beta-AgonistsPhase 4, Phase 21266
10Adrenergic AgonistsPhase 4, Phase 22331
11Adrenergic AgentsPhase 4, Phase 24204
12Immunologic FactorsPhase 4, Phase 3, Phase 2, Phase 118483
13Respiratory System AgentsPhase 4, Phase 23931
14Bronchodilator AgentsPhase 4, Phase 22377
15Fluticasone Propionate, Salmeterol Xinafoate Drug CombinationPhase 4, Phase 2136
16
Salmeterol xinafoatePhase 4, Phase 232694749-08-356801
Synonyms:
(+-)-4-Hydroxy-alpha(sup 1)-(((6-(4-phenylbutoxy)hexyl)amino)methyl)-m-xylene-alpha,alpha'-diol 1-hydroxy-2-naphthoate (salt)
(+/-) 4-Hydroxy-a1-[[[6-(4-phenylbutoxy)hexyl]amino]m-ethyl]-1,3-benzenedimethanol xinafoate
1,3-Benzenedimethanol, 4-hydroxy-alpha(sup 1)-(((6-(4-phenylbutoxy)hexyl)amino)methyl)-, (+-)-, 1-hydroxy-2-naphthalenecarboxylate (salt)
1-hydroxynaphthalene-2-carboxylic acid
2-(hydroxymethyl)-4-[1-hydroxy-2-[6-(4-phenylbutoxy)hexylamino]ethyl]phenol
89365-50-4 (Parent)
94749-08-3
AC1L1LPS
Arial
Asmerole
Beglan
Betamican
Bio-0096
C25H37NO4.C11H8O3
CHEMBL1082607
CID56801
D00687
Dilamax
EU-0101100
GR 33343 G
GR 33343X xinafoate
 
GR-33343 G
Inaspir
LS-94516
MLS001332577
MLS001332578
MolPort-003-850-218
NCGC00094372-01
NCGC00094372-02
NCGC00094372-03
NCGC00094372-04
S5068_SIGMA
SMR000875207
Salmetedur
Salmeterol 1-hydroxy-2-naphthoate
Salmeterol xinafoate (JAN/USAN)
Salmeterol xinafoate [USAN]
Serevent (TN)
Serevent Inhaler and Disks
Serevent diskus
UNII-6EW8Q962A5
Ultrabeta
salmeterol xinafoate
17Antibodies, MonoclonalPhase 4, Phase 3, Phase 22413
18
FluticasonePhase 4, Phase 258990566-53-3, 80474-14-262924, 22833648
Synonyms:
90566-53-3
AC-456
AC1NSJZT
Asmatil
Axotide
BIDD:GT0819
Brethal
C07815
CHEMBL1201396
CID5311101
Cultivate
Cutivate
D07981
Flixonase
Flixonase Nasal Spray
Flixotide
Flixotide Disk
 
Flixotide Disks
Flixotide Inhaler
Flonase
Flovent
Flovent Diskus
Flovent Rotadisk
Fluinol
Flunase
Flusonal
Fluspiral
Fluticaps
Fluticaps (TN)
Fluticasone (INN)
Fluticasonpropionat Allen
Flutide
Flutivate
MolPort-006-666-449
S-(fluoromethyl) (6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carbothioate
fluticasone
19Dermatologic AgentsPhase 4, Phase 24555
20AntiemeticsPhase 43213
21Neurotransmitter AgentsPhase 4, Phase 214795
22Tocolytic AgentsPhase 4, Phase 2561
23AlbuterolPhase 4, Phase 2384
24ImmunoglobulinsPhase 4, Phase 3, Phase 24477
25Anti-Inflammatory AgentsPhase 4, Phase 2, Phase 38478
26AntibodiesPhase 4, Phase 3, Phase 24477
27Methylprednisolone acetatePhase 41082
28Antineoplastic Agents, HormonalPhase 4, Phase 2, Phase 34256
29Hormones, Hormone Substitutes, and Hormone AntagonistsPhase 4, Phase 2, Phase 39988
30Gastrointestinal AgentsPhase 46401
31Hormone AntagonistsPhase 4, Phase 2, Phase 310002
32HormonesPhase 4, Phase 2, Phase 311748
33glucocorticoidsPhase 4, Phase 2, Phase 33896
34Methylprednisolone HemisuccinatePhase 41082
35Protective AgentsPhase 4, Phase 2, Phase 15651
36Anti-Allergic AgentsPhase 4, Phase 21312
37Anti-Asthmatic AgentsPhase 4, Phase 22796
38Neuroprotective AgentsPhase 41376
39Prednisolone phosphatePhase 41082
40Peripheral Nervous System AgentsPhase 4, Phase 218510
41Prednisolone acetatePhase 41082
42Prednisolone hemisuccinatePhase 41082
43Tiotropium BromidePhase 4311
44BromidesPhase 4523
45Cholinergic AgentsPhase 43243
46Cholinergic AntagonistsPhase 41423
47Muscarinic AntagonistsPhase 4961
48ParasympatholyticsPhase 4902
49Leukotriene AntagonistsPhase 4270
50Contraceptives, OralPhase 43734

Interventional clinical trials:

(show all 50)
idNameStatusNCT IDPhase
1The Efficacy of Three Months-prednisolone Therapy for Chronic Eosinophilic PneumoniaCompletedNCT00632554Phase 4
2Small Particle Steroids in Refractory AsthmaCompletedNCT01171365Phase 4
3Efficacy of Omalizumab in Adults (18-60 Years of Age) With Moderate-Severe, Persistent Allergic Asthma, Despite Receiving Inhaled Corticosteroids and Long Acting Beta-agonistsCompletedNCT00670930Phase 4
4Omalizumab to Mepolizumab Switch Study in Severe Eosinophilic Asthma PatientsRecruitingNCT02654145Phase 4
5Exhaled NO Based Treatment of Chronic Obstructive Pulmonary Disease (COPD), ICS/LABA Versus LAMAActive, not recruitingNCT02546349Phase 4
6Effect of Xolair on Airway HyperresponsivenessActive, not recruitingNCT00208234Phase 4
7Efficacy and Safety of add-on Montelukast to Inhaled Budesonide in the Treatment of Nonasthmatic Eosinophilic BronchitisNot yet recruitingNCT01121016Phase 4
8A Study to Evaluate the Efficacy and Safety of Reslizumab in Patients With Eosinophilic AsthmaCompletedNCT01285323Phase 3
9A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic AsthmaCompletedNCT01270464Phase 3
10A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic AsthmaCompletedNCT01287039Phase 3
11Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe AsthmaCompletedNCT01508936Phase 3
12Association Corticosteroid/Azathioprine in Microscopic Polyangiitis/ Polyarteritis Nodosa or Eosinophilic Granulomatosis With Polyangiitis (Churg Strauss Syndrome)CompletedNCT00647166Phase 3
13Effects of Mepolizumab Compared to Placebo on Airway Physiology in Patients With Eosinophilic Asthma: MEMORY StudyRecruitingNCT02594332Phase 3
14Cessation Versus Continuation of Long-term Mepolizumab in Severe Eosinophilic Asthma PatientsRecruitingNCT02555371Phase 3
15Mepolizumab Treatment for Rhinovirus-induced Asthma ExacerbationsRecruitingNCT01520051Phase 3
16Study of Efficacy and Safety of QAW039 in Patients With Severe Asthma Inadequately Controlled With Standard of Care Asthma Treatment.RecruitingNCT02563067Phase 3
17Study of Efficacy and Safety of QAW039 in Patients With Severe Asthma Inadequately Controlled With Standard of Care Asthma Treatment.RecruitingNCT02555683Phase 3
18Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Participants With Severe Eosinophilic Asthma on Markers of Asthma ControlActive, not recruitingNCT02281318Phase 3
19A Phase 3a, Repeat Dose, Open-label, Long-term Safety Study of Mepolizumab in Asthmatic SubjectsActive, not recruitingNCT02135692Phase 3
20Anti-Interleukin-5 (IL5) Monoclonal Antibody (MAb) in Prednisone-dependent Eosinophilic AsthmaEnrolling by invitationNCT02559791Phase 2, Phase 3
21Open-Label Extension Study to Evaluate the Long-Term Safety and Efficacy of Reslizumab (3.0 mg/kg) as Treatment for Patients (12 Through 75 Years of Age) With Eosinophilic AsthmaTerminatedNCT01290887Phase 3
22A Phase IIa Study of KHK4563CompletedNCT01412736Phase 2
23Efficacy, Safety, and Tolerability of SAR231893 (REGN668) in Patients With Persistent Moderate to Severe Eosinophilic AsthmaCompletedNCT01312961Phase 2
24A Study to Evaluate the Effectiveness of a Drug (MEDI-563) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01227278Phase 2
25Anti-Interleukin-5 Antibody to Treat Hypereosinophilic SyndromeCompletedNCT00017862Phase 2
26Safety and Efficacy of QAW039 in Sputum Eosinophilia and Persistent AsthmaCompletedNCT01545726Phase 2
27Intravenous Mepolizumab In Subjects With Hypereosinophilic Syndromes (HES)CompletedNCT00086658Phase 2
28OC000459 Bronchial Allergen ChallengeCompletedNCT01056692Phase 2
29Safety and Efficacy Study of OC000459 Dosed Twice Daily for 28 Days in Asthmatic SubjectsCompletedNCT01057927Phase 2
30Imatinib Mesylate in Patients With Various Types of Malignancies Involving Activated Tyrosine Kinase EnzymesCompletedNCT00171912Phase 2
31Pharmacokinetics and Pharmacodynamics of Mepolizumab Administered Subcutaneously in ChildrenRecruitingNCT02377427Phase 2
32Effect of OC459 on the Response to Rhinovirus Challenge in AsthmaRecruitingNCT02660489Phase 2
33Study to Evaluate Safety and Efficacy of Dexpramipexole (KNS-760704) in Subjects With Hypereosinophilic SyndromeRecruitingNCT02101138Phase 2
34Study to Evaluate Safety and Efficacy of Benralizumab in Subjects With Hypereosinophilic SyndromeRecruitingNCT02130882Phase 2
35Investigation of Lung Ventilation Inhomogeneity in Pediatric AsthmaActive, not recruitingNCT01095354Phase 2
36Effect of OC000459 on Eosinophilic Airway Inflammation in Severe AsthmaNot yet recruitingNCT02560610Phase 2
37Effect of House Dust Mite Allergen Challenge in Persons Using 1200 mg Gamma Tocopherol SupplementsCompletedNCT00466596Phase 1
38Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral TherapyCompletedNCT00890747Phase 1
39Sirolimus for Eosinophil-Associated Gastrointestinal DisordersTerminatedNCT01814059Phase 1
40Modification of Asthma With Soy IsoflavoneCompletedNCT00741208
41Activation and Function of Eosinophils in Conditions With Blood or Tissue EosinophiliaRecruitingNCT00001406
42Functional Activity of Airway Eosinophils in Allergic DiseaseRecruitingNCT01026532
43A Longitudinal Study of Familial Hypereosinophilia (FE): Natural History and Markers of Disease ProgressionRecruitingNCT00091871
44The Factors Associated With the Formation of Nasal polyp-a Case Control and Descriptive StudyRecruitingNCT01278719
45Myeloproliferative Neoplasms (MPNs) Patient RegistryRecruitingNCT02760238
46Usefulness of Exhaled NO in the Differential Diagnosis Acute Eosinophilic Pneumonia and Bacterial PneumoniaActive, not recruitingNCT01152424
47Use of a Probiotic Supplement to Prevent Asthma in InfantsActive, not recruitingNCT00113659
48Clinico-biological Correlation of Severe Asthma in ChildrenActive, not recruitingNCT02038374
49Immuno-ablation With Chemoimmunoradiation and Autologous Stem Cell Transplant for Churg-Strauss SyndromeNot yet recruitingNCT02728271Phase 0
50Early Antiinflammatory Treatment of AsthmaTerminatedNCT00567463

Search NIH Clinical Center for Pulmonary Eosinophilia

Genetic Tests for Pulmonary Eosinophilia

About this section

Anatomical Context for Pulmonary Eosinophilia

About this section

MalaCards organs/tissues related to Pulmonary Eosinophilia:

33
Lung, Breast, T cells, Heart, Prostate, Endothelial, Myeloid

Animal Models for Pulmonary Eosinophilia or affiliated genes

About this section

MGI Mouse Phenotypes related to Pulmonary Eosinophilia:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053886.7CCL11, CCR3, CSF2, CYSLTR1, IL13, IL4
2MP:00053976.6CCL11, CCR3, CSF2, EPX, IL13, IL4
3MP:00053875.8CCL11, CCR3, CSF2, CYSLTR1, EPX, IL13

Publications for Pulmonary Eosinophilia

About this section

Articles related to Pulmonary Eosinophilia:

(show top 50)    (show all 284)
idTitleAuthorsYear
1
Host lung immunity is severely compromised during tropical pulmonary eosinophilia: role of lung eosinophils and macrophages. (26489428)
2015
2
Natural helper cells contribute to pulmonary eosinophilia by producing IL-13 via IL-33/ST2 pathway in a murine model of respiratory syncytial virus infection. (26044350)
2015
3
Regulatory T cells prevent Th2 immune responses and pulmonary eosinophilia during respiratory syncytial virus infection in mice. (23926350)
2013
4
Acquired alpha 1-antitrypsin deficiency in tropical pulmonary eosinophilia. (21808138)
2011
5
Oral tolerance inhibits pulmonary eosinophilia in a cockroach allergen induced model of asthma: a randomized laboratory study. (21092270)
2010
6
Transient pulmonary eosinophilia incidentally found on low-dose computed tomography: findings in 40 individuals. (18303297)
2008
7
Death receptor-6 regulates the development of pulmonary eosinophilia and airway inflammation in a mouse model of asthma. (16730379)
2006
8
Elevated levels of fragmented laminin-5 gamma2-chain in bronchoalveolar lavage fluid from dogs with pulmonary eosinophilia. (16624727)
2006
9
Simple pulmonary eosinophilia evaluated by means of FDG PET: the findings of 14 cases. (16374077)
2005
10
OX40 ligation on activated T cells enhances the control of Cryptococcus neoformans and reduces pulmonary eosinophilia. (12794142)
2003
11
Differential susceptibility of C57BL/6 and DBA/2 mice to ovalbumin-induced pulmonary eosinophilia regulated by Th1/Th2-type cytokines. (10569702)
1999
12
Primary role of CD4+ T cells and supplemental role of mast cells in allergic pulmonary eosinophilia. (10529596)
1999
13
Pulmonary eosinophilia associated with montelukast. (10335014)
1999
14
Tropical pulmonary eosinophilia presenting as hydro-pneumothorax with broncho-pleural fistula. (10999107)
1999
15
Pathogenesis of tropical pulmonary eosinophilia: parasitic alveolitis and parallels with asthma. (9519215)
1998
16
Tropical pulmonary eosinophilia. Report of a case. (9515101)
1997
17
Recurrent post-partum pulmonary eosinophilia. (9516905)
1997
18
Eotaxin triggers eosinophil-selective chemotaxis and calcium flux via a distinct receptor and induces pulmonary eosinophilia in the presence of interleukin 5 in mice. (8784786)
1996
19
Characterization of the antigen-presenting cell and T cell requirements for induction of pulmonary eosinophilia in a murine model of asthma. (8938110)
1996
20
Syndrome resembling tropical pulmonary eosinophilia but of non-filarial aetiology: serological findings with filarial antigens. (8560543)
1995
21
Minocycline and pulmonary eosinophilia. (7787604)
1995
22
A case of tropical pulmonary eosinophilia. (7948545)
1994
23
Adrenal function & the pattern of glucocorticoid induced eosinopenia in tropical pulmonary eosinophilia. (8225446)
1993
24
Maloprim-induced pulmonary eosinophilia. (8417912)
1993
25
Tropical pulmonary eosinophilia in a 63-year-old woman from Guyana. (8324690)
1993
26
Pulmonary eosinophilia with systemic features: therapy and prognosis. (1470705)
1992
27
Pulmonary eosinophilia in pulmonary tuberculosis. (1600796)
1992
28
Correlation of lower respiratory tract inflammation with changes in lung function and chest roentgenograms in patients with untreated tropical pulmonary eosinophilia. (1876879)
1991
29
Electrocardiographic abnormalities in tropical pulmonary eosinophilia. (2148545)
1990
30
Rash and pulmonary eosinophilia associated with fenbufen. (2137356)
1990
31
Pulmonary eosinophilia and granulomatous pulmonary arteritis induced in rats by intravenous Sephadex. (1698322)
1990
32
Corticosteroid treatment and prognosis in pulmonary eosinophilia. (2595633)
1989
33
Airway hyperreactivity in tropical pulmonary eosinophilia. (3359833)
1988
34
Pulmonary eosinophilia associated with cutaneous larva migrans. (3969661)
1985
35
Hepatic involvement in tropical pulmonary eosinophilia. (6501178)
1984
36
Tropical pulmonary eosinophilia: an unusual presentation. (6618529)
1983
37
Epidemiology of bancroftian filariasis in East Godavari district (Andhra Pradesh)--incidence of tropical pulmonary eosinophilia. (7040222)
1981
38
Lipodystrophy and pulmonary eosinophilia. (7228604)
1981
39
Clinical studies in pulmonary eosinophilia. II--Relation of blood eosinophilia and pulmonary manifestations in clinic patients and urban population. (721166)
1978
40
Immunoglobulins in byssinosis, chronic bronchitis and pulmonary eosinophilia. (730695)
1978
41
Pulmonary eosinophilia. Netaji oration. Part II. (730723)
1978
42
Adrenaline and tropical pulmonary eosinophilia. (1248889)
1976
43
Cytophilic antibodies in bronchopulmonary aspergilloma and cryptogenic pulmonary eosinophilia. (63346)
1976
44
Drug-induced lung disease: pulmonary eosinophilia and sulphonamides. (1236549)
1975
45
Leukocyte adhesion phenomenon in pulmonary eosinophilia (tropical eosinophilia). (4683591)
1973
46
PRELIMINARY STUDIES ON THE PRODUCTION OF EXPERIMENTAL PULMONARY EOSINOPHILIA BY TISSUE ANTIGEN ANTIBODY REACTION OF THE HOST. (14235491)
1964
47
Pulmonary eosinophilia; report of a case. (13413195)
1957
48
Prolonged pulmonary eosinophilia; a report on three cases. (14363706)
1955
49
Myelitis following arsenic therapy in pulmonary eosinophilia. (13017551)
1952
50
Pulmonary eosinophilia (tropical eosinophilia). (18152220)
1949

Variations for Pulmonary Eosinophilia

About this section

Expression for genes affiliated with Pulmonary Eosinophilia

About this section
Search GEO for disease gene expression data for Pulmonary Eosinophilia.

Pathways for genes affiliated with Pulmonary Eosinophilia

About this section

Pathways related to Pulmonary Eosinophilia according to GeneCards Suite gene sharing:

(show all 28)
idSuper pathwaysScoreTop Affiliating Genes
19.8CCL11, RNASE3
29.8IL4, IL5
39.7EPX, RNASE3
4
Show member pathways
9.5IL13, IL5, RNASE3
59.4CCL11, IL4, IL5
6
Show member pathways
9.4CCL11, IL4, RNASE3
7
Show member pathways
9.4IL13, IL4, IL5
89.4IL13, IL4, IL5
99.4IL13, IL4, IL5
109.4IL13, IL4, IL5
11
Show member pathways
9.2CSF2, IL4, IL5
12
Show member pathways
9.1CCL11, IL4, SFTPD
139.0CCL11, IL13, IL4, IL5
149.0CSF2, RNASE3, SFTPD
15
Show member pathways
9.0CCL11, CCR3, RNASE3
16
Show member pathways
8.9CSF2, IL4, IL5, RNASE3
178.9CSF2, IL13, IL4, IL5
188.9CSF2, IL13, IL4, IL5
198.8CSF2, EPX, IL4, IL5
20
Show member pathways
8.5CSF2, IL13, IL4, IL5, RNASE3
21
Show member pathways
8.3CCL11, EPX, IL13, IL4, IL5, RNASE3
22
Show member pathways
8.3CCL11, EPX, IL13, IL4, IL5, RNASE3
23
Show member pathways
8.1CSF2, EPX, IL13, IL4, IL5, RNASE3
248.0CCR3, CSF2, EPX, IL4, IL5
25
Show member pathways
7.7CCL11, CCR3, CSF2, IL13, IL4, IL5
26
Show member pathways
7.4CCL11, CCR3, CSF2, IL13, IL4, IL5
27
Show member pathways
7.4CCL11, CCR3, CSF2, IL13, IL4, IL5
28
Show member pathways
6.9CCL11, CCR3, CSF2, EPX, IL13, IL4

GO Terms for genes affiliated with Pulmonary Eosinophilia

About this section

Biological processes related to Pulmonary Eosinophilia according to GeneCards Suite gene sharing:

(show all 14)
idNameGO IDScoreTop Affiliating Genes
1negative regulation of complement-dependent cytotoxicityGO:190366010.4IL13, IL4
2regulation of proton transportGO:001015510.3IL13, IL4
3positive regulation of mast cell degranulationGO:004330610.3IL13, IL4
4positive regulation of immunoglobulin productionGO:000263910.2IL13, IL4
5positive regulation of tyrosine phosphorylation of Stat5 proteinGO:004252310.1CSF2, IL4
6microglial cell activationGO:000177410.1IL13, IL4
7myeloid dendritic cell differentiationGO:004301110.0CSF2, IL4
8dendritic cell differentiationGO:009702810.0CSF2, IL4
9positive regulation of B cell proliferationGO:00308909.9IL13, IL4, IL5
10positive regulation of endothelial cell proliferationGO:00019389.7CCL11, CCR3
11chemokine-mediated signaling pathwayGO:00700989.4CCL11, CCR3
12positive regulation of GTPase activityGO:00435479.3CCL11, CSF2, IL5
13positive regulation of cell proliferationGO:00082849.2CSF2, IL4, IL5
14immune responseGO:00069558.2CCL11, CSF2, IL13, IL4, IL5

Sources for Pulmonary Eosinophilia

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet